Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD)

Trial Phase 2 Completed May 19, 2020

Improving Walking Automaticity in Parkinson's Disease: Levodopa or Donepezil

Trial Early Phase 1 Completed May 10, 2020

Mobility Rehab, a Therapist-assisted System for Gait Rehabilitation

Trial N/A Unknown May 10, 2020

Effects of iVR Treadmill on Gait in PD

Trial N/A Completed May 5, 2020

Effects of Neuromodulation on Brain Electric Activity of Parkinson's Disease Patients

Trial N/A Unknown May 3, 2020

Effects of Intensity-matched Agility and Cycling Exercise Training on PD Patients' Clinical Symptoms, Posture, and Mobility

Trial N/A Completed May 3, 2020

Agility Training in Parkinson's Disease

Trial N/A Completed April 30, 2020

Two-year Follow-up to High-intensity Multi-component Agility Intervention That Improves Clinical and Motor Symptoms of Parkinson's Disease

Trial N/A Completed April 30, 2020

Compare the Effects of Agility and Cycling Exercise Training on Mobility and Balance in PD and Healthy Old Adults

Trial N/A Completed April 27, 2020

Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia

Trial Phase 2 Completed April 27, 2020

Use of Noninvasive Brain Stimulation in Parkinson's Disease

Trial N/A Completed April 23, 2020

Feasibility of Two New Software Modules for the Rehabilitation of Patients With Neuromuscular Upper Limb Impairments

Trial N/A Withdrawn April 20, 2020

Electronic-health Application To Measure Outcomes REmotely Clinical Trial

Trial N/A Completed April 19, 2020

Safety and Efficacy of CERE-120 in Subjects With Parkinson's Disease

Trial Phase 1 Completed April 15, 2020

Ambroxol in Disease Modification in Parkinson Disease

Trial Phase 2 Completed April 14, 2020

Evaluation of [18F]MNI-1126 as an Imaging Marker for Synaptic Density Loss

Trial Phase 1 Completed April 14, 2020

TMS Treatment in Parkinson's Disease With Pain.

Trial N/A Completed April 14, 2020

Phase I, KM-819 in Healthy Subjects for Parkinson's Disease

Trial Phase 1 Completed April 12, 2020

Serotonin in Impulse Control Disorders in Parkinson's Disease

Trial N/A Unknown April 7, 2020

Molecular and Functional Imaging in SNCA, Parkin and PINK1

Trial N/A Withdrawn April 5, 2020